Galway medtech developing a stent to treat intracranial atherosclerotic disease and stroke.
| Date | Round | Amount |
|---|---|---|
| Feb 2024 | Funding round Ceroflo raised EUR 6.4m, including EUR 5m via an EIIS scheme led by DHKN, to fund its first human clinical trial of its stroke-treatment stent. | $6.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.